Successful sample preparation for serial crystallography experiments by Beale, John H et al.
1Appendix A
Supplementary Information
A.1. A brief word on seeds and seeding
A.1.1. Protein crystal seedsa) b) c)
100 μm 10 μm500 μm
Fig. 6. Visualisation of the steps used to generate T. album Proteinase K
seeds. a) shows the initial large crystals in a 24-well sitting drop plate prior to
crushing with a pipette tip. b) and c) are scanning electron microscopy images
of the seeds plunge frozen on electron microscopy grids after pipette crushing and
three rounds of vortexing, respectively.
Seeds can be thought of as any form of protein crystals, or in fact, any scaffold
molecule (see Appendix A.1.2), that when added to the protein reservoir solution
mixture, act as nucleants for crystal growth (Stura & Wilson, 1992). When thinking
about seeding in terms of controlling crystal size, it can be broadly divided into macro
and micro-seeding protocols. Macro-seeding is where large crystals (typically > 100
µm) are used as single nucleants to grow very large crystals (not discussed further, see
Lee et al. (2018) for a nice example). Micro-seeding is where previously grown crystals
are broken up and ground down to make a cloud of nano-crystalline fragments (Luft
& DeTitta, 1999; Ireton & Stoddard, 2004). These fragments retain some crystalline
structure and act as a scaffold for other protein molecules to aggregate upon in an
ordered manner.
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2There are several different ways of making a successful micro-crystal or more prob-
ably, nano-crystal seed-stock (Table 2). All involve taking larger crystals, probably
grown in vapour diffusion plates, and fragmenting them with small hard spheres. Fig-
ure 6 gives an overview of the process using Proteinase K crystals from Tritirachium
album with the aid of a scanning electron microscope (SEM). The result of the first
step, crushing the seed crystals (Figure 6a) is shown in Figure 6b and the final seed
stock after the three rounds of vortexing is shown in Figure 6c. A more homogeneous
seed stock was shown to increase the resolution limit of crystals grown from the seeds
(Dods et al., 2017).
A.1.2. Heterogeneous nucleation Another method, that should be mentioned in con-
junction with seeding, is heterogeneous nucleation. This method was first demon-
strated by McPherson & Shlichta (1988) and has since evolved such that there are
now a range of small molecule molecular scaffolds (Ino et al., 2011) and porous mate-
rials (Chayen et al., 2006; Nanev et al., 2017) that have been shown to be effective
protein crystal nucleants. In the context of micro-crystal growth, if a given protein’s
propensity to nucleate was increased by the presence of one of these materials, the
material could theoretically be used in the same manner as a protein crystal seed stock,
enabling the rate of nucleation to be directly controlled. This has not been attempted
in this work but could, in theory, be successfully employed as an alternative to protein
crystal seeded-batch.
A.2. Example optimisation of enhanced Green Fluorescent Protein from vapour diffu-
sion to batch
Enhanced Green Fluorescent Protein (eGFP), adapted to increase its fluorescent
emission and codon optimised for mammalian expression from Aequorea victoria (Zhang
et al., 1996), was gradually optimised from vapour diffusion to batch using the crys-
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tallisation time as the key heuristic (Figure 7). This optimisation was performed in 
96-well Greiner CrystalQuick™ 3-drop, 96-well plate (Figure 10a) using a reservoir vol-
ume of 90 µL and a different drop ratio in each of the wells: 1:1, 1:2 and 2:1, protein 
to reservoir solution. The protein was concentrated to 55 mg/mL post purification in 
50 mM HEPES pH 8.0, 0.1 M MgCl2 and crystals were observed after 20 days from a 
condition in a MORPHEUS (Molecular Dimensions) sparse matrix screen (Figure 7a).
However, the complexity of condition (90 mM Nitrate Phosphate Sulfate (NPS)
additives, 0.1 M Tris/BICINE pH 8.5, 37.5 % (v/v) Precipitant Mix 4) and the appear-
ance of salt crystals within the drop, made optimisation challenging. The protein was
exchanged into 50 mM HEPES pH 8.5, 0.15 M NaCl and re-screened. A hit was now
observed after 14 days in JSCG+ (Molecular Dimensions): 0.1 M BisTris Propane pH
6.5, 0.2 M NaBr, 20 % (w/v) PEG 3350 (Figure 7b). These crystals could be recre-
ated (Figure 7c) and the crystallisation time reduced to 8 days by increasing the PEG
concentration and pH to 21.6 % and 7.15, respectively.
No precipitation was visible when using an eGFP concentration of 55 mg/mL, so
the concentration was increased to 120 mg/mL. Interestingly, crystals did grow at
this protein concentration, but only in the 1:2 protein to reservoir drop and with the
pH and PEG concentration reduced to 6.5 and 18.2 %, respectively. Figure 7d and
e shows eGFP micro-crystal growth after 24 and 48 hr, respectively. To better view
these crystals, Figure 7f shows an electron micrograph of the crystals from Figure 7e.
The crystals are approximately 0.5 nm wide with the longest dimension of between 5
and 30 µm. Although these crystals still require further optimisation for SMX, this is
an example of how to find the nucleation zone and optimise towards batch.
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Fig. 7. The steps taken to move from an initial vapour diffusion hit to a
batch-like crystallisation process for eGFP. a) to e) show images of eGFP
crystals in Greiner CrystalQuick™ 96-well plates. The crystals in f) were removed
from the well in e) and vitrified on an electron microscopy grid.
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5A.3. Insulin and thermolysin phase diagrams
The phase diagrams of bovine insulin crystallised in 0.1 M BisTris Propane pH 7.5,
0.2 M KI, PEG 3,350 and thermolysin from Geobacillus stearothermophilus crystallised
in 0.2 M NH4Cl, PEG 3350, nicely illustrate the importance of crystallisation rates
when designing large scale batch protocols (Figure 8).
The nucleation rate of insulin appeared to be proportional to both the concentration
of insulin and the concentration of PEG 3,350 (Figure 8a and c) and did not appear
to be affected by the presence of seeds except at 25 mg/mL. These data suggested
that in the context of a micro-crystallisation starting point, both seeded-batch and
batch crystallisation techniques were viable strategies and that high protein and PEG
concentrations would be necessary.
Thermolysin, by comparison, had a larger nucleation zone but a relatively low nucle-
ation rate (Figure 8b and d). Adding seeds to the crystallisation condition gave near-
perfect nucleation parity across all drops in the nucleation and metastable zones. This
suggested that thermolysin nucleation in this condition was slow and that the addi-
tion of seeds could overcome any nascent nucleating power that would otherwise exist.
It was also apparent that increasing the protein concentration in solution had little
to no effect on the number of nucleation events. Therefore, when considering micro-
crystallisation conditions for thermolysin from this condition, a seeded-batch method
would be advisable and a low protein concentration should yield equally good results
as a high concentration. In this case, understanding of the phase diagram would allow
for greater economy of the protein sample.
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Fig. 8. Phase diagrams for insulin and thermolysin. The raw plots for bovine
insulin and G. stearothermophilus thermolysin are shown in a) and b), respec-
tively. The plots are based on two 96 condition crystallisation experiments, with
and without seeds (see § 3.1). The size of each circle corresponds to the approximate
number of crystals observed in the crystallisation drop. The opaque and shadowed
circles show the number of crystals present from drops with no seeds and seeds,
respectively. The red lines refer to the approximate boundaries between the differ-
ent zones of the diagram. c) and d) are representations of the plots shown in a)
and b), respectively where darker shading indicates regions of higher nucleation
or blurring between the region division. The crystallisation drop images that are
shown highlight the differing scales of nucleation between different regions of the
plot for insulin and thermolysin. The red scale bars in the images denote 600 µm.
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7A.4. UbiX scaling
a) b)
300 μm 100 μm
Fig. 9. Scaling UbiX crystallisation to 100 µL. a) and b) i llustrate the final
scaling challenge encountered for UbiX when scaled to 100 µL. a) show the crystal
clumping observed when using seeds and b), no seeds.
Attempts to scale UbiX using a seeded-batch protocol for larger volumes proved
challenging. The seeded crystals tended to clump together (Figure 9a) and could
not be separated without damaging the integrity of clumped crystals. Therefore, a
straight batch protocol in 96-well, chimney-well plates (see Figure 10d) was created. 
The final crystal concentration was lower than the seeded method, approximately
6 × 104 crystals/mL. However, the final crystals remained small (10 − 15 µm) and 
the clumping was significantly reduced (Figure 9b), so ultimately, the straight batch
protocol proved more successful.






Fig. 10. Useful tools to scale small volume batch crystallisation conditions
to larger volumes. a) 96-well Greiner CrystalQuick™ 3-drop, b) SWISSCI MRC
under-oil plate, c) Greiner 72-well Terizaki microplate, d) 96-well F-Bottom (chim-
ney well) microplate, e) Hawksley hemocytometer, f) Eppendorf thermomixer with
centrifuge tube adaptor, g) Thermo Scientific™ tube revolver/rotator, h) Eppendorf
thermomixer with plate adaptor.
IUCr macros version 2.1.1: 2009/05/11
9A.6. Scaling tips
Scaling problem Possible solution
Heterogenous crystal size In larger batch volume crystallisation, where nucle-
ation can happen more slowly, crystals can often
sink and stick to the side or bottom of the crys-
tallisation vessel. If nucleants become buried, they
are unable to grow, whilst non-buried crystals are
exposed to more free protein and grow too large.
Vortexing, either gently (10 − 20 rpm) or rapidly
(> 1000 rpm) can help to alleviate this problem.
The precise level of agitation will be protein and
condition-specific. Anecdotally, smaller (< 200 µL)
and larger (> 500 µL) volumes might require more
and less agitation, respectively.
Crystal clumping Crystals in scaled batch conditions can clump
together and/or stick to the bottom of the crystalli-
sation vessel post-growth. Often, gentle pipetting
of the crystallisation solution around the vessel is
enough to remove these sticky crystals. However, if
they refuse to move, gently sonicating the container
in a sonication bath for 10− 30 s can help the crys-
tals to lift off the sides of the vessel or break apart
without apparent adverse effects to the crystals.
Degradation of seed stocks If a seeded batch protocol is being used, a plan for
the creation and storage of seed-stocks is required.
A seed-stock, once created can be stored at −20 °C
however, repeated freeze-thaw has been found to
erode the potency of the stock and therefore reduce
the level of nucleation observed. To overcome this,
it can be useful to store seed-stocks as aliquots,
such that seeds only undergo a single cycle of freeze-
thaw.
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Variations in temperature and
humidity
It has been noted that the success of a batch pro-
tocol can often depend on its location. A protocol
that has been successful in one laboratory can often
fail when it is applied in a different laboratory. The
reason for this perhaps, is that batch protocols are
often conducted on the lab bench as opposed to the
more controlled environment of an incubator. Sub-
tle differences in temperature and humidity between
laboratories exist that lead to different results. If
a well-defined protocol is failing in different loca-
tions, the crystallisation could be sensitive to these
changes. An answer here is to use heat blocks (Fig-
ure 10f) or humidity tents to control temperature
and humidity as much as possible.
Micro-crystals grow too large Quenching, i.e. stopping the progress of the crys-
tallisation experiment, can be useful when the crys-
tal size goes beyond the limit of the sample delivery
approach being used (Kupitz et al., 2014). Although
perhaps not ideal, as quenching by definition means
that there is wasted protein in solution, the tech-
nique is definitely useful if a crystallisation protocol
is in all other respects satisfactory and a pragmatic
appraisal suggests that ‘this is good enough’.
Table 1: Frequently observed problems when optimis-
ing and scaling batch crystallisation conditions for
SMX.
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A.7. Crystallisation tips
Other tips and tricks Notes
Varying protein & reservoir vol-
ume ratios
This idea is referred to in general terms in § 2.1 and
the eGFP example in Appendix A.2 is a nice exam-
ple. The standard drop ratio of 1:1 protein to reser-
voir solution is a variable that, when altered, can
yield powerful results. In § 2.1 a suggestion is made
to vary this at the stage of finding batch versions of
a sitting-drop experiment. This is ideal, as it limits
the sample burden to a stage in the process where
200 nL experiments are being performed. However,
when scaling to larger volumes, tweaks in the ratio
(anecdotally less protein, more reservoir) can help
push the crystallisation experiment to greater levels
of nucleation.
Just add seeds This, in many ways, is perhaps the easiest path
to micro-crystallisation. For many vapour diffusion
crystallisation conditions, the condition starts in the
metastable region, i.e. the protein is already super-
saturated but unable to nucleate. The vapour dif-
fusion equilibration time would allow the drop to
slowly migrate to the nucleation zone and spon-
taneous nucleation, however, the addition of seeds
negates this and dictates the level of nucleation. The
danger of solely relying on this approach is that any
knowledge about the manner of protein crystallisa-
tion is lost, and therefore any understanding of the
limits of the phase diagram regions. However, just
adding seeds can be very quick and effective.
Standardising seed stocks The key here is to standardise the protocol for cre-
ating the crystals which are going to be made into
seeds, such that there is little variation between
the size and number of crystals in the wells. In the
authors’ opinion, the best way to do this is to grow
the seed crystals in a vapour diffusion plate and
then collect the crystals from a standardised num-
ber of drops each time the seed stock is made. Varia-
tions in crystals size and number between drops will
average out across the pooled drops and if a more
concentrated seed-stock is required, the number of
pooled drops can be easily increased. The creation
of a more concentrated stock which can then be
diluted will also lead to greater reproducibility.
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Serial seeding Serial seeding involves multiple rounds of seeding
where crystals are produced using seeds that orig-
inate from a preceding crystal growth, i.e. crystals
produced using an initial set of seeds are subse-
quently used to make a second set of seeds etc. By
undertaking multiple rounds of serial seeding both
crystal homogeneity and diffraction quality can be
improved (Bergfors, 2003; Bunker et al., 2012; Dods
et al., 2017; Ibrahim et al., 2015).
Seed homogenisation The standard method of producing crystal seeds is
by vortexing larger crystals in a centrifuge tube con-
taining a single Seed Bead™ (Hampton Research
- Hampton now sell four different seed bead kits:
PTFE, steel, ceramic and glass) or multiple small
beads. This breaks up the crystals into smaller frag-
ments, yet these fragments are unlikely to be com-
pletely homogeneous in size and some large frag-
ments are likely to remain. To minimise the presence
of larger fragments, the seed stock can be filtered or
centrifuged at 2,000 rpm for 20−30 s in a benchtop
centrifuge.
Testing micro-crystal diffraction It is essential that the diffraction quality of any
micro-crystals is tested before the serial experi-
ment, particularly if the experiment is happening
at an XFEL. If a crystal does not diffract at a syn-
chrotron, it is unlikely to diffract at an XFEL.
Standard protein stock Given the large volumes of protein required
throughout the development of a large-scale, batch
crystallisation protocol, time spent maximising the
efficiency of the protein preparation protocol is even
more necessary. Variations in the protein prepa-
ration can affect the crystallisation significantly,
therefore, the more available protein which comes
from identical preparations, the greater the chance
of minimising differences in protein solution.
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Crystal crushing If the crystallisation experiment does not respond 
well to quenching or other methods to reduce the 
crystal size, it is possible to crush larger crystals 
(> 50 µm) in order to make a suitably sized crystal 
slurry (Dods et al., 2017; de la Cruz et al., 2017)1. 
However, this is not ideal and crushing should per-
haps be used as a last resort. The authors have 
not extensively tried this approach, on a single 
occasion when it worked successfully, a very short 
(< 1 − 2 s) vortex of the crystalline slurry with a 
Seed Bead™ (Hampton) was all that was required. 
Too long or too short a vortex and the crystals did 
not mount successfully. When the crushing was suc-
cessful, there was a corresponding drop of 0.2 − 0.5
A˚ in diffracted resolution compared to an uncrushed
crystal which diffracted to 2.5 A˚ (data are not
shown).
Table 2: Some other tips and ideas on how to scale




Bovine insulin (I5500, Sigma-Aldrich) was solubilised in 50 mM sodium hydro-
gen phosphate pH 10.5, 10 mM ethylenediaminetetraacetic acid (EDTA), to a final
concentration of 25 mg/mL. Thermolysin from G. stearothermophilus (T7902, Sigma-
Aldrich) was solubilised in 20 mM MES pH 6.0, 45 % (v/v) DMSO to a final con-
centration of 100 mg/mL. Proteinase K from T. album (P2308, Sigma-Aldrich) was
solubilised in 25 mM Tris pH 7.5 to a final concentration of 50 mg/mL. These solutions
1 In the case of Dods et al. (2017), they specifically showed how crystal-crushing, followed by rounds of 
seeding could produce a viable sample - essentially a seeded-batch protocol - and de la Cruz et al.(2017) 
were making protein samples suitable for electron diffraction experiments.
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were then filtered through a 0.2 µm centrifugal filter (EMD Millipore), flashed-cooled 
in liquid nitrogen and stored at −80 °C until used.
eGFP (UniProtKB: C5MKY7) was cloned into pOPINF2 (Berrow et al., 2007), and 
expressed in E. coli strain BL21-DE3. Transfected cells were grown at 37 °C with con-
stant aeration until an OD600 ≈ 0.5. At which point the temperature was reduced to 25 
°C and cells were induced by the addition of IPTG. Cells were harvested after 
approximately 16 hr by centrifugation and lysed by a combination of freeze/thaw and 
cell disruption (Constant Systems). The recombinant protein was purified using Ni-
immobilized metal affinity chromatography, firstly to separate fusion protein from cell 
lysate and then, post-His-tag cleavage, to remove the tag, protease and any remaining 
lysate material. Protein was then passed through a 1660 Superdex S75 (GE Health-
care) gel filtration column equilibrated in 50 mM HEPES pH 8.5, 0.15 M NaCl, con-
centrated, flash cooled in liquid nitrogen and stored at −80 °C until used.
B.2. Crystallisation
Cubic bovine insulin crystals suitable for the generation of seeds were grown in 
Greiner CrystalQuick™, 96-well sitting drop plates with a reservoir volume of 90 µL 
and a final drop of 400 nL; 1:1 protein to precipitant solution. Insulin solution was 
mixed with a reservoir solution; 0.1 M BisTris Propane pH 7.5, 0.1 M KI and 22 %
(w/v) PEG 3,350. The same protocol was used to create thermolysin seed crystals but 
with a reservoir solution of 22 % (w/v) PEG 3,350, and 0.2 M ammonium chloride 
and 20 % (w/v) PEG 3,350. After approximately 24 hr the crystals could be harvested 
for seeding purposes. Crystals from 5 drops were pooled in 250 µL of crystallisation 
buffer and ten to fifteen 1 mm glass milled beads (Fisher Scientific) were added to 
this solution. The solution was then alternately vortexed and cooled on ice every 30 s 
from three cycles. This stock was then frozen and stored at −20 °C until required.
2 https://www.oppf.rc-harwell.ac.uk/OPPF/protocols/popin/gb/pOPINF.gb 
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Proteinase K crystals were grown in a 24-well sitting drop plate (Mitegen). Pro-
teinase K solution was mixed in a 1:1 ratio with 0.2 M NH4Cl, 20 % (w/v) PEG 3,350
to a final volume of 10 µL. Crystals appeared after 6 hr and grew for a further 24 at
20 °C.
B.3. Scanning electron microscopy
Samples were cryo-cooled on glow-discharged Cu 200 mesh Quantifoil™ R 2/2 elec-
tron microscopy grids (Quantifoil). First, a 2 µL aliquot of well solution was applied to
the Cu side of the grid, then 2 µL of the slurry of crystals was applied onto the carbon
film. The grid was then blotted for 4.0 s from the Cu side of the grid using a Leica
EM GP plunge freezer. During this process, the chamber environment of the Leica
EM GP was set to 20 °C and 90 % humidity. After blotting, grids were immediately
plunge frozen in liquid ethane and then transferred to liquid nitrogen for storage until
further use.
SEM images were taken using a JEOL JSM-IT100 SEM equipped with a Quorum
PP3000T cryostage and cryotransfer system. The PP3000T cryostage, preparation
stage and anticontaminator were cooled to −180 °C, −180 °C and −190 °C, respec-
tively. The crystal seeds were imaged using an accelerating voltage of 5 kV and a beam
current of 47 pA.
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